SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)

por Capdevila, Jaume, Gómez, Ma Auxiliadora, Guillot, Mónica, Páez, David, Pericay, Carles, Safont, Maria José, Tarazona, Noelia, Vera, Ruth, Vidal, Joana, Sastre, Javier
Publicado 2022

Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021)

por Capdevila, Jaume, Gómez, Ma Auxiliadora, Guillot, Mónica, Páez, David, Pericay, Carles, Safont, Maria José, Tarazona, Noelia, Vera, Ruth, Vidal, Joana, Sastre, Javier
Publicado 2022

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents

por García-Alfonso, Pilar, Ferrer, Ana, Gil, Silvia, Dueñas, Rosario, Pérez, María Teresa, Molina, Raquel, Capdevila, Jaume, Safont, María José, Castañón, Carmen, Cano, Juana María, Lara, Ricardo
Publicado 2015

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

por Salazar, Ramon, Capdevila, Jaume, Laquente, Berta, Manzano, Jose Luis, Pericay, Carles, Villacampa, Mercedes Martínez, López, Carlos, Losa, Ferran, Safont, Maria Jose, Gómez, Auxiliadora, Alonso, Vicente, Escudero, Pilar, Gallego, Javier, Sastre, Javier, Grávalos, Cristina, Biondo, Sebastiano, Palacios, Amalia, Aranda, Enrique
Publicado 2015

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

por Elez, Elena, Pericay, Carles, Valladares-Ayerbes, Manuel, Bando, Inmaculada, Safont, Maria Jose, Gallego, Javier, Grávalos, Cristina, Arrivi, Antonio, Carrato, Alfredo, Conde, Verónica, Ortiz, Maria José, López, Carlos, Alonso, Beatriz, Ruiz de Mena, Inmaculada, Díaz-Rubio, Eduardo, Tabernero, Josep, Aranda, Enrique
Publicado 2019

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenoc...

por Salazar, Ramón, Capdevila, Jaume, Manzano, Jose Luis, Pericay, Carles, Martínez-Villacampa, Mercedes, López, Carlos, Losa, Ferrán, Safont, María José, Gómez-España, Auxiliadora, Alonso-Orduña, Vicente, Escudero, Pilar, Gallego, Javier, García-Paredes, Beatriz, Palacios, Amalia, Biondo, Sebastiano, Grávalos, Cristina, Aranda, Enrique
Publicado 2020

Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials

por Benavides, Manuel, Díaz-Rubio, Eduardo, Carrato, Alfredo, Abad, Albert, Guillén, Carmen, Garcia-Alfonso, Pilar, Gil, Silvia, Cano, María Teresa, Safont, María José, Gravalos, Cristina, Manzano, José Luis, Sánchez, Antonio, Alcaide, Julia, López, Rafael, Massutí, Bartomeu, Sastre, Javier, Martínez, Eva, Escudero, Pilar, Méndez, Miguel, Aranda, Enrique
Publicado 2019

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study

por Vera, Ruth, Gómez, María Luisa, Ayuso, Juan Ramón, Figueras, Joan, García-Alfonso, Pilar, Martínez, Virginia, Lacasta, Adelaida, Ruiz-Casado, Ana, Safont, María José, Aparicio, Jorge, Campos, Juan Manuel, Cámara, Juan Carlos, Martín-Richard, Marta, Montagut, Clara, Pericay, Carles, Vieitez, Jose María, Falcó, Esther, Jorge, Mónica, Marín, Miguel, Salgado, Mercedes, Viúdez, Antonio
Publicado 2020

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

por García-Alfonso, Pilar, Díaz-Rubio, Eduardo, Abad, Albert, Carrato, Alfredo, Massutí, Bartomeu, Ortiz-Morales, María José, Manzano Mozo, José Luis, Muñoz, Andrés, Durán, Gema, Sastre, Javier, Safont, María José, Ferreiro, Reyes, Rivera, Fernando, González, Encarnación, Valladares-Ayerbes, Manuel, Grávalos, Cristina, Alonso-Orduña, Vicente, Viéitez, José María, Yubero, Alfonso, Aranda, Enrique
Publicado 2021

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

por Aranda, Enrique, Viéitez, Jose Maria, Gómez-España, Auxiliadora, Gil Calle, Silvia, Salud-Salvia, Antonieta, Graña, Begoña, Garcia-Alfonso, Pilar, Rivera, Fernando, Quintero-Aldana, Guillermo Alfonso, Reina-Zoilo, Juan José, González-Flores, Encarnación, Salgado Fernández, Mercedes, Guillén‑Ponce, Carmen, Garcia-Carbonero, Rocio, Safont, María José, La Casta Munoa, Adelaida, García-Paredes, Beatriz, López López, Rafael, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado 2020

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study

por Valladares-Ayerbes, Manuel, Garcia-Alfonso, Pilar, Muñoz Luengo, Jorge, Pimentel Caceres, Paola Patricia, Castillo Trujillo, Oscar Alfredo, Vidal-Tocino, Rosario, Llanos, Marta, Llorente Ayala, Beatriz, Limon Miron, Maria Luisa, Salud, Antonieta, Cirera Nogueras, Luis, Garcia-Carbonero, Rocio, Safont, Maria Jose, Falco Ferrer, Esther, Aparicio, Jorge, Vicente Conesa, Maria Angeles, Guillén-Ponce, Carmen, Garcia-Teijido, Paula, Medina Magan, Maria Begoña, Busquier, Isabel, Salgado, Mercedes, Lloansí Vila, Ariadna
Publicado 2022